According to Sage Therapeutics 's latest financial reports the company's current EPS (TTM) is -9,50ย โฌ. In 2022 the company made an earnings per share (EPS) of -8,60ย โฌ a decrease over its 2021 EPS that were of -7,47ย โฌ.